Sign In
Buy SVFC
$15.81
+0 (+0%)
At Close: Sep 27, 2022
IntelliCell Filed Patent Application for its Proprietary Method of Manufacturing Stromal Vascular Fraction Cells
09:12am, Thursday, 26'th Jan 2012
NEW YORK--(BUSINESS WIRE)--IntelliCell BioSciences, Inc. (OTCQB: SVFC) (PINKSHEETS: SVFC); (“IntelliCell”) or the (“Company”), December 27, 2010 IntelliCell filed its patent application with t
NEW YORK--(BUSINESS WIRE)--IntelliCell Biosciences, Inc. (OTCQB: SVFC) (PINKSHEETS: SVFC); (“IntelliCell”) or the (“Company”), IntelliCell has licensed its proprietary, patent pending technolo
NEW YORK--(BUSINESS WIRE)--Intellicell Biosciences, Inc. (OTCQB: SVFC) (PINKSHEETS: SVFC); (“Intellicell”) or the (“Company”), Intellicell has licensed its proprietary, patent, pending technol
NEW YORK--(BUSINESS WIRE)--First graph, third sentence of release should read: IntelliCell’s notable Advisory Board additions include: James R. Andrews, M.D.; Joshua Hackel, M.D.; Jeffrey R. Dugas,
